{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:56:17Z","timestamp":1776318977955,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Vancomycin-resistant\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      (VREF) is a leading cause of nosocomial bacteremia, with mortality rates exceeding 60%. Current animal models lack translational relevance due to the divergence in immune systems between rodents and humans.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To establish a rabbit model of\n                      <jats:italic>Enterococcus faecium<\/jats:italic>\n                      infection for evaluating therapeutic regimes, specifically monoclonal antibody (mAb) therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We established a reproducible rabbit model of acute VREF bacteremia using New Zealand White rabbits (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a020) intravenously challenged with 1 \u00d7 10\n                      <jats:sup>9<\/jats:sup>\n                      CFU\/g of VREF (strain E155). The animals were divided into three groups: uninfected controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a06), infected untreated (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a07), and infected treated with mAb 8AP (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a07). We histopathologically examined the kidneys, lungs, spleen, heart, and liver, and quantified bacterial loads. Plasma cytokine levels were measured to assess inflammatory responses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Infected untreated rabbits exhibited significant weight loss, sustained fever (&amp;gt;40\u00a0\u00b0C, peaking at 39h), and 20% mortality within 12h. Systemic bacterial dissemination was confirmed in all organs examined, with the spleen showing the highest bacterial load and the liver exhibiting the most severe histopathological damage (necrosis and suppurative inflammation). The mAb 8AP treatment significantly improved clinical outcomes: heart and respiratory rates decreased, and body weight increased compared with untreated infected rabbits. Cytokine profiling showed elevated levels of IL-6, IL-8, and IL-10, consistent with systemic inflammatory response syndrome (SIRS), with the mAb treatment showing a trend toward immune modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This model successfully simulates human VREF bacteremia and demonstrates the therapeutic potential of mAb 8AP. The rabbit model provides a clinically relevant platform for evaluating novel immunotherapies for VREF infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1619290","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:13Z","timestamp":1776317173000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A rabbit model of acute bacteremia and sepsis caused by vancomycin-resistant Enterococcus faecium"],"prefix":"10.3389","volume":"16","author":[{"given":"Karen","family":"Flores-Moreno","sequence":"first","affiliation":[{"name":"Programa de Inmunolog\u00eda Molecular Microbiana, Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Ciudad de M\u00e9xico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Arredondo-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Laboratorio de Microbioma, Divisi\u00f3n de Investigaci\u00f3n, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Ciudad de M\u00e9xico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mayoral-Ter\u00e1n","sequence":"additional","affiliation":[{"name":"Programa de Inmunolog\u00eda Molecular Microbiana, Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Ciudad de M\u00e9xico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"L\u00f3pez-Vidal","sequence":"additional","affiliation":[{"name":"Programa de Inmunolog\u00eda Molecular Microbiana, Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Ciudad de M\u00e9xico, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"B1","volume-title":"Inmunolog\u00eda Celular y Molecular","author":"Abbas","year":"2008"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010013","article-title":"Pro-inflammatory and anti-inflammatory interleukins in infectious diseases: a comprehensive review","author":"Al-Qahtani","year":"2024","journal-title":"Trop. Med. Infect. Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3855\/jidc.20800","article-title":"Interleukin-6 as a biomarker of sepsis and its clinical utility in predicting mortality: a prospective observational study","volume":"19","author":"Ameen","year":"2025","journal-title":"J. Infect. Dev. Ctries"},{"key":"B4","author":"Arduino","year":"1994"},{"key":"B5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"B6","first-page":"1","article-title":"Application of rabbits in biomedical research: a review","volume-title":"World Rabbit Science","author":"Bosze","year":"2006"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jac\/dkab069","article-title":"Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis","volume":"76","author":"Casta\u00f1eda","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/AAC.00589-16","article-title":"Daptomycin-\u03b2-lactam combinations in a rabbit model of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis","volume":"60","author":"Chambers","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"22","author":"Duan","year":"2022","journal-title":"Front. Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0094-1","article-title":"The wide utility of rabbits as models of human diseases","volume":"50","author":"Esteves","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.gpp3-0053-2018","article-title":"Pathogenicity of enterococci","volume":"7","author":"Fiore","year":"2019","journal-title":"Microbiol. Spectr"},{"key":"B12","volume-title":"Enterococci: From commensals to leading causes of drug resistant infection","author":"Gilmore","year":"2014"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1080\/21505594.2017.1279766","article-title":"Model systems for the study of enterococcal colonization and infection","volume":"8","author":"Goh","year":"2017","journal-title":"Virulence"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00788","article-title":"Global emergence and dissemination of Enterococci as nosocomial pathogens: attack of the clones","volume":"7","author":"Guzman Prieto","year":"2016","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"21502","DOI":"10.1074\/jbc.M301476200","article-title":"Species-specific regulation of Toll-like receptor 3 genes in men and mice","volume":"278","author":"Heinz","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/iai.68.8.4631-4636.2000","article-title":"Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and-resistant Enterococci","volume":"68","author":"Huebner","year":"2000","journal-title":"Infect Immun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/AAC.44.9.2545-2546.2000","article-title":"Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance","volume":"44","author":"Kak","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","volume-title":"RM-NZW-rabbit-Information-Sheet","author":"Kathleen Pritchett-Corning","year":"2011"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1128\/AAC.47.11.3515-3518.2003","article-title":"Influence of VanD type resistance on activities of glycopeptides In Vitro and in experimental endocarditis due to Enterococcus faecium","volume":"47","author":"Lefort","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.2076","article-title":"IL-10 helps control pathogen load during high-level bacteremia","volume":"181","author":"Londo\u00f1o","year":"2008","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11908-012-0270-8","article-title":"Enterococcal endocarditis: can we win the war","volume":"14","author":"Munita","year":"2012","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/1753425915606209","article-title":"Genetic characterization of interleukins (IL-1\u03b1, IL-1\u03b2, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs","volume":"21","author":"Neves","year":"2015","journal-title":"Innate Immun."},{"key":"B23","volume-title":"Harkness and Wagner\u2019s Biology and Medicine of Rabbits and Rodents","author":"Patricia V. Turner","year":"2025"},{"key":"B24","first-page":"499","article-title":"Rabbit models for studying human infectious diseases","volume":"65","author":"Peng","year":"2015","journal-title":"Comp. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00251-015-0868-8","article-title":"An overview of the lagomorph immune system and its genetic diversity","volume":"68","author":"Pinheiro","year":"2016","journal-title":"Immunogenetics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1128\/AAC.00646-13","article-title":"Efficacy of tigecycline alone and in combination with gentamicin in the treatment of experimental endocarditis due to linezolid-resistant Enterococcus faecium","volume":"57","author":"Pontikis","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10393-004-0151-1","article-title":"Animals as sentinels of human environmental health hazards: an evidence-based analysis","volume":"2","author":"Rabinowitz","year":"2005","journal-title":"Ecohealth"},{"key":"B28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1574-695x.2000.tb01489.x","article-title":"Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium","volume":"28","author":"Rakita","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B29","doi-asserted-by":"crossref","unstructured":"Genome-based analysis of Enterococcus faecium bacteremia associated with recurrent and mixed-strain infection\n          \n          \n            \n              Raven\n              K. E.\n            \n            \n              Gouliouris\n              T.\n            \n            \n              Parkhill\n              J.\n            \n            \n              Peacock\n              S. J.\n            \n          \n          10.1128\/JCM.01520-17\n          29263205\n          J Clin Microbiol.\n          56\n          2018","DOI":"10.1128\/JCM.01520-17"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118405","article-title":"Isolation of highly active monoclonal antibodies against multiresistant gram-positive bacteria","volume":"10","author":"Rossmann","year":"2015","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nrmicro3308","article-title":"Models matter: the search for an effective Staphylococcus aureus vaccine","volume":"12","author":"Salgado-Pab\u00f3n","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00160-22","article-title":"Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections","volume":"37","author":"Sauvat","year":"2024","journal-title":"Clin. Microbiol. Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981815","article-title":"The rabbit as an animal model to study innate immunity genes: is it better than mice","volume":"13","author":"Soares","year":"2022","journal-title":"Front. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3109\/01902149109063278","article-title":"Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung","volume":"17","author":"Steven L. Kunkel","year":"1990","journal-title":"Exp. Lung Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of Toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1682306","article-title":"Cytokines in sepsis: a critical review of the literature on systemic inflammation and multiple organ dysfunction","volume":"16","author":"Vella","year":"2025","journal-title":"Front. Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41579-024-01058-6","article-title":"Enterococcus faecium: evolution, adaptation, pathogenesis and emerging therapeutics","volume":"22","author":"Wei","year":"2024","journal-title":"Nat. Rev. Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect. Ctrl Hosp Epidemiol"},{"key":"B39","article-title":"WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"B40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ajem.2016.12.017","article-title":"Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria","volume":"35","author":"Yan","year":"2017","journal-title":"Am. J. Emergency Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ccc.2009.08.005","article-title":"Animal models of sepsis","volume":"25","author":"Zanotti-Cavazzoni","year":"2009","journal-title":"Crit. Care Clinics"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1619290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:26:15Z","timestamp":1776317175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1619290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":41,"alternative-id":["10.3389\/fcimb.2026.1619290"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1619290","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"1619290"}}